Table of Contents
Metal-Based Drugs
Volume 2010 (2010), Article ID 286298, 6 pages
http://dx.doi.org/10.1155/2010/286298
Research Article

Cytotoxic Properties of Titanocenyl Amides on Breast Cancer Cell Line MCF-7

Department of Chemistry, University of Puerto Rico, P.O. Box 9019, Mayagüez, PR 00681, USA

Received 18 November 2009; Accepted 16 February 2010

Academic Editor: Alberta Bergamo

Copyright © 2010 Li Ming Gao and Enrique Meléndez. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Köpf and P. Köpf-Maier, “Titanocene dichloride-the first metallocene with cancerostatic activity,” Angewandte Chemie International Edition, vol. 18, no. 6, pp. 477–478, 1979. View at Google Scholar
  2. P. Köpf-Maier, “Complexes of metals other than platinum as antitumour agents,” European Journal of Clinical Pharmacology, vol. 47, no. 1, pp. 1–16, 1994. View at Google Scholar
  3. P. Köpf-Maier and H. Köpf, “Organometallic titanium, vanadium, niobium, molybdenum and rhenium complexes early transition metal antitumor drugs,” in Metal Compounds in Cancer Therapy, S. P. Fricker, Ed., pp. 109–146, Chapman and Hall, London, UK, 1994. View at Google Scholar
  4. M. M. Harding and G. Mokdsi, “Antitumour metallocenes: structure-activity studies and interactions with biomolecules,” Current Medicinal Chemistry, vol. 7, no. 12, pp. 1289–1303, 2000. View at Google Scholar
  5. E. Meléndez, “Titanium complexes in cancer treatment,” Critical Reviews in Oncology/Hematology, vol. 42, no. 3, pp. 309–315, 2002. View at Publisher · View at Google Scholar
  6. F. Caruso and M. Rossi, “Antitumor titanium compounds,” Mini-Reviews in Medicinal Chemistry, vol. 4, no. 1, pp. 49–60, 2004. View at Publisher · View at Google Scholar
  7. F. Caruso and M. Rossi, “Antitumor titanium compounds and related metallocenes,” Metal Ions in Biological Systems, vol. 42, pp. 353–384, 2004. View at Google Scholar
  8. I. Kostova, “Titanium and vanadium complexes as anticancer agents,” Anti-Cancer Agents in Medicinal Chemistry, vol. 9, no. 8, pp. 827–842, 2009. View at Publisher · View at Google Scholar
  9. L. M. Gao, J. Matta, A. L. Rheingold, and E. Meléndez, “Synthesis, structure and biological activity of amide-functionalized titanocenyls: improving their cytotoxic properties,” Journal of Organometallic Chemistry, vol. 694, no. 26, pp. 4134–4139, 2009. View at Publisher · View at Google Scholar · View at PubMed
  10. A. Gansäuer, D. Franke, T. Lauterbach, and M. Nieger, “A modular and efficient synthesis of functional Titanocenes,” Journal of the American Chemical Society, vol. 127, no. 33, pp. 11622–11623, 2005. View at Publisher · View at Google Scholar · View at PubMed
  11. A. Gansäuer, I. Winkler, D. Worgull et al., “Modular synthesis of functional Titanocenes,” Organometallics, vol. 27, p. 5699, 2008. View at Google Scholar
  12. T. Mossman, “Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxycity assays,” Journal of Immunological Methods, vol. 65, p. 55, 1983. View at Google Scholar
  13. F. Denizot and R. Lang, “Rapid colorimetric assay for cell growth and survival—modifications to the tetrazolium dye procedure giving improved sensitivity and reliability,” Journal of Immunological Methods, vol. 89, no. 2, pp. 271–277, 1986. View at Google Scholar
  14. D. Si, X. Wang, Y.-H. Zhou et al., “Mechanism of CYP2C9 inhibition by flavones and flavonols,” Drug Metabolism and Disposition, vol. 37, no. 3, pp. 629–634, 2009. View at Publisher · View at Google Scholar · View at PubMed
  15. A. Gansäuer, I. Winkler, D. Worgull, T. Lauterbach, L. FraWagner, and A. Prokop, “Carbonyl-substituted Titanocenes: a novel class of cytotoxic compounds with high antitumor and antileukemic activity,” Chemistry—A European Journal, vol. 14, p. 4160, 2008. View at Google Scholar
  16. O. R. Allen, L. Croll, A. L. Gott, R. J. Knox, and P. C. McGowan, “Functionalized cyclopentadienyl titanium organometallic compounds as new antitumor drugs,” Organometallics, vol. 23, no. 2, pp. 288–292, 2004. View at Publisher · View at Google Scholar
  17. H. Weber, J. Claffey, M. Hogan, C. Pampillón, and M. Tacke, “Analyses of Titanocenes in the spheroid-based cellular angiogenesis assay,” Toxicology in Vitro, vol. 22, no. 2, pp. 531–534, 2008. View at Publisher · View at Google Scholar · View at PubMed
  18. O. Oberschmidt, A. R. Hanauske, C. Pampillón, N. J. Sweeney, K. Strohfeldt, and M. Tacke, “Antiproliferative activity of titanocene Y against tumor colony-forming units,” Anti-Cancer Drugs, vol. 18, no. 3, pp. 317–321, 2007. View at Publisher · View at Google Scholar · View at PubMed
  19. C. Pampillón, N. J. Sweeney, K. Strohfeldt, and M. Tacke, “Synthesis and cytotoxicity studies of new dimethylamino-functionalised and heteroaryl-substituted titanocene anti-cancer drugs,” Journal of Organometallic Chemistry, vol. 692, no. 11, pp. 2153–2159, 2007. View at Publisher · View at Google Scholar
  20. K. O'Connor, C. Gill, M. Tacke et al., “Novel titanocene anti-cancer drugs and their effect on apoptosis and the apoptotic pathway in prostate cancer cells,” Apoptosis, vol. 11, no. 7, pp. 1205–1214, 2006. View at Publisher · View at Google Scholar · View at PubMed
  21. P. Beckhove, O. Oberschmidt, A. R. Hanauske et al., “Antitumor activity of Titanocene Y against freshly explanted human breast tumor cells and in xenografted MCF-7 tumors in mice,” Anti-Cancer Drugs, vol. 18, no. 3, pp. 311–315, 2007. View at Publisher · View at Google Scholar · View at PubMed
  22. A. Vessières, M.-A. Plamont, C. Cabestaing et al., “Proliferative and anti-proliferative effects of titanium- and iron-based metallocene anti-cancer drugs,” Journal of Organometallic Chemistry, vol. 694, no. 6, pp. 874–879, 2009. View at Publisher · View at Google Scholar
  23. J. Claffey, B. Gleeson, M. Hogan, H. Müller-Bunz, D. Wallis, and M. Tacke, “Fluorinated derivatives of titanocene Y: synthesis and cytotoxicity studies,” European Journal of Inorganic Chemistry, no. 26, pp. 4074–4082, 2008. View at Publisher · View at Google Scholar
  24. S. Eger, T. A. Immel, J. Claffey et al., “Titanocene difluorides with improved cytotoxic activity,” Inorganic Chemistry, vol. 49, no. 4, pp. 1292–1294, 2010. View at Publisher · View at Google Scholar · View at PubMed
  25. M. Ravera, E. Gabano, S. Baracco, and D. Osella, “Electrochemical evaluation of the interaction between antitumoral titanocene dichloride and biomolecules,” Inorganica Chimica Acta, vol. 362, p. 1303, 2009. View at Google Scholar
  26. T. Kapp, S. Müller, and R. Gust, “Dinuclear alkylamine platinum(II) complexes of [1,2-bis(4-fluorophenyl) ethylenediamine]-platinum(II): influence of endocytosis and copper and organic cation transport systems on cellular uptake,” ChemMedChem, vol. 1, no. 5, pp. 560–564, 2006. View at Publisher · View at Google Scholar · View at PubMed